SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
米团
Lv2
130 积分
2022-09-05 加入
最近求助
最近应助
互助留言
Response criteria for phase II studies of supratentorial malignant glioma
14天前
已完结
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
14天前
已完结
Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer
14天前
已完结
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
14天前
已完结
Prolonged Oral Hydroxyurea and Concurrent 3d-Conformal Radiation in Patients with Progressive or Recurrent Meningioma: Results of a Pilot Study
14天前
已完结
Non-Resectable Slow-Growing Meningiomas Treated by Hydroxyurea
14天前
已完结
Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningiomas
14天前
已完结
Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF
2个月前
已关闭
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
3个月前
已完结
没有进行任何应助
暂不需要【积分已退回】
2个月前
十分感谢!
3个月前
本文章的Supplementary Appendix
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论